Creating the Future of Digital Health
We are Surgalign, a global medical technology company committed to the promise of digital health. We are investing to be a leader in developing and harnessing the incredible possibilities of digital surgery to redefine the very idea of “personalized medicine.”
We began operating as Surgalign in July 2020, but with a legacy of clinically validated surgical device and biologic innovation stretching back 30 years. We are dedicated to advancing care and elevating outcomes. Surgalign markets products in the United States and in approximately 50 countries globally.
From Pioneer Surgical to RTI Surgical to Surgalign to the addition of our powerful HOLO™ AI technology, here are some of the significant milestones in a journey that has brought us to the foothills of possibility.
RTI Biologics Inc. completes the acquisition of Pioneer® Surgical Technology to become RTI Surgical, Inc.
Portfolio of spine products is modernized with launch of Fortilink® IBF System with TETRAfuse® 3D Technology as well as acquisitions of Zyga Technology, Inc. (SImmetry SI Joint Fusion System) and Paradigm Spine, LLC, (Coflex® Interlaminar Stabilization® device).
RTI Surgical and Aziyo® Biologics announce exclusive agreement to distribute ViBone®.
Surgalign Spine Technologies is created. A "new" company with a nearly 30 year heritage solely focused on advancing spine surgery and elevating clinical outcomes.
Surgalign acquires Chicago-based Holo Surgical Inc and its powerful artificial intelligence and augmented reality guidance technology.
The U.S. Food & Drug Administration grants 510(k) clearance to Surgalign’s HOLO Portal™ surgical guidance powered by HOLO AI Technology. Surgalign also acquires a significant equity interest in Intenueral Networks Inc.